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1. Introduction
Since the introduction of laparoscopic surgery, minimally invasive techniques have been
widely used for benign and malignant diseases. [1, 2] Although many surgeons perform
laparoscopic colectomy for benign diseases, its application for colorectal malignancy had slow
progress because of oncological considerations. [3] Over time, many randomized controlled
trials have been published comparing open to laparoscopic surgery for colorectal cancer, which
show that in experienced hands, competent oncology resections can be performed the results
are equivalent to open surgery [4-7]. However, the results of the minimally invasive surgery
for rectal cancer have not been thoroughly investigated and large multicenter randomized
trials are underway.
Large number of randomized controlled trials comparing laparoscopic to open surgery for
colon cancer have established better short-term results - less pain, shorter length of stay, faster
return of bowel function and equivalent oncological outcomes [2-5]. Laparoscopic rectal
surgery is still developing with promising short-term benefit, although depending on the skills
and techniques of the surgeon [6]. Surgery of rectal cancer requires more technical skills (total
mesorectal excision, low pelvic anastomosis), many fear that the oncological principles could
be compromised during laparoscopic resection. In addition to oncological concerns, the
widespread of laparoscopic surgery for colorectal cancer is impeded by the significant learning
curve.
Hand-assisted techniques introduced in the 1990s were an attempt to overcome some of these
limitations and provide an overlap between open and laparoscopic techniques and the
transition from open to minimally invasive surgery for many surgeons [1, 8]. Acceptance of
minimally invasive procedures by patients and surgeons led to the developent of new
technologies to ease the laparoscopic approach. The introduction of single incision laparo‐
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scopic surgery (SILS) devices has allowed fewer cuts. [9] The clinical application of endoscopic
natural orifice transluminal surgery (NOTES) in colorectal disease is not yet fully accepted,
but it was possible great advances in instrumentation and improving techniques for specimen
extraction after laparoscopic colectomy [12].
2. Systemic benefits
Basic science studies have demonstrated the better preservation of oncological and immuno‐
logical functions after laparoscopic surgery before trials on humans [7-9], thus giving hope for
better long-term oncologic outcome. Tumor cells are found in systemic blood circulation and
in the peritoneal fluid immediately after surgery and if they survive may avoid the immuno‐
logical defense of the organism. The surgical trauma causes immunological alterations and the
organism might be vulnerable during the postoperative period [7-9]. Laparoscopic surgery
causes lesser trauma and therefore less effect on the immune system, decreases the prolifera‐
tion stimuli for cancer cells and neoangiogenesis [7-9, 11]. The changes can last shortly after
the operation, but some are observed after months or longer [11]. These potential advantages
do not provide better long-term outcomes in human trials, although some report better
oncological results after laparoscopic surgery in terms of longer cancer-related survival and
less tumor recurrences [10-14].
The rate of conversion to open surgery is still very high, as demonstrated by three multicenter
prospective trials - the NCI Clinical Outcomes of Surgical Therapies (COST; 21%), Colon
Cancer Laparoscopic or Open Resection (COLOR; 17%), and the Conventional versus Lapa‐
roscopic-Assisted Surgery in Colorectal Cancer (CLASICC; 29%) [15, 16]. This could be due to
more precautious behavior of the surgeons and their inexperience.
A meta-analysis from 2006 demonstrated intriguing results. It includes 1134 patients after
colectomy in two periods – 1996-2000 and 2000-2004. Laparoscopic colectomy was introduced
as an option only in the second period. The authors found that 3-year overall survival
decreased in the latter, while the overall survival of patients after open colectomy remained
the same over the two periods. [17]
Intracorporeal anastomosis for right laparoscopic colectomy improved patient outcome
compared with patients who underwent extracorporeal anastomosis. There is found faster
recovery of nutrition, faster recovery of intestinal function, and shorter hospitalization.
However, there was no difference in average surgery time between the two groups.
According to the differences in age, gender, BMI, ASA class, or abdominal surgical history, in
laparoscopic colectomy with extracorporeal anastomosis (laparoscopic-assisted colectomy),
the bowel is externalized through a lateral mini-incision. With this approach, bowel mobili‐
zation and ligation of vessels is usually laparoscopic, whereas resection of the specimen and
creation of the anastomosis is extracorporeal. On the other hand, in laparoscopic right
colectomy with intracorporeal anastomosis (totally laparoscopic colectomy), bowel mobiliza‐
tion, ligation of vessels, resection of the specimen, and creation of the anastomosis are totally
intracorporeal.
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Regarding oncological radicality, there are significant differences in the number of lymph
nodes removed. An average of 19 lymph nodes from the intracorporeal group and 14 lymph
nodes from the extracorporeal group are reported to be removed. In the literature, some
authors have reported no differences in safety, whereas others noted that the only advantage
was a smaller incision. On the other hand, other studies affirmed the safety of intracorporeal
anastomosis, with the same complication rate as for extracorporeal anastomosis. Because
intracorporeal anastomosis is considered more difficult, only a few surgeons have used this
kind of technique; however less mobilization is required, and less tension is applied to the
bowel and mesentery because the bowel does not need to reach the anterior abdominal wall
for externalization. [11] Furthermore, the excessive tension on the mesentery during the
mobilization is associated with an increased risk of mesenteric or portal vein thrombosis.
Concerning surgical times, there is not a significant difference in surgical time between the
two groups. Patients in the intracorporeal group had a shorter hospitalization duration. In
some cases, the hospitalization duration was longer possibly because of age (43.2% of patients
in the intracorporeal group and 33.4% in the extracorporeal group were over 80 years old).
Our results showed a significantly shorter average hospitalization stay in the intracorporeal
group. These data agree with a recent Spanish study, although this difference was not
significant (P = 0.5424) because hospitalization duration is influenced by many patient factors.
On the other hand, we found that 71.4% of patients in the intracorporeal group went home
within 7 d, and 54.7% of patients in the extracorporeal group went home within this period.
[20, 21] Patients in the intracorporeal group and extracorporeal group went home within 7 d.
Concerning the recovery of intestinal function, our results found significantly shorter average
times for resumption of gas evacuation after 3 d in the intracorporeal group compared to after
3.8 d in the extracorporeal group. Bowel movements occurred after an average of 4.9 d in the
intracorporeal group. In the intracorporeal group, the nasogastric tube was removed after 1.8
d, whereas it was removed after 3 d in the extracorporeal group. This difference can be
explained by an increased percentage of paralytic ileus in the second group, which is due to
the traction of the right colon and terminal ileum through the mini-incision on the pancreas
and duodenum. This approach allowed a more rapid recovery of liquid and solid nutrition
consumption. [25-27] There are met some major complications, which included severe anemia,
occlusion, anastomotic dehisces, and enterocutaneous fistulae. There were no significant
differences between the two groups.
In conclusion, our study clearly shows that laparoscopic right colectomy with intracorporeal
anastomosis improves patient outcome. Intracorporeal anastomosis resulted in faster recovery
of nutrition consumption, faster recovery of intestinal function, and shorter hospitalization
duration. The higher number of lymph nodes removed seems to be related to vascular division
as the first surgical step as a rule. This confirms that a mini invasive approach improves patient
outcome.
3. Port site metastasis
The early trials of laparoscopic colectomy have established high rate of tumor recurrence near
the port wounds, which was considered a serious drawback of the new approach. The etiology
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is unclear, although some authors suggest poor surgical technique and tumor biology as a
probable cause. The reported rate in the early trials reached 21%. Recent trials (Hughes et al.,
1603 patients, [15] found the rate to be 0.68%. Fleshman et al. [5] reported results based on the
NCI COST trial, which demonstrated comparable rates for open and laparoscopic surgery after
5- and 8-year follow up (0.5% and 0.9%, respectively). The Barcelona trials had similar outcome
after a median follow-up of 95 months [7]. The European randomized controlled study, the
Colon Cancer Laparoscopic or Open Resection (COLOR) trial (2009) established after 53-month
median follow-up that the port site metastasis rate was 0.4% after open (n=542) and 1.3% after
laparoscopic colectomy (n=534). [19] The location of the recurrences was near the extraction
port (n=2) and near the trocar sites (n=5) [5]. Recent studies do not report such high recurrence
rates.
Proper training and the use of safe oncologic techniques are essential in the prevention of port
site metastases. Such safe techniques are the routing use of wound protectors, less instrument
exchange, avoidance of direct trauma to the tumor, avoidance of inadvertent desufflation.
4. Enhanced recovery after surgery
The approach employs a multimodal perioperative care pathway with the aim of attenuating
the stress response to surgery and accelerating recovery [21]. Implementation of enhanced
recovery protocols has led to improved outcomes across a range of different specialties
including reductions in postoperative morbidity and hospital stay [61-65]. The fundamental
premise of ERAS is the incorporation of evidence-based practice. It would seem to follow
therefore that the evolution of enhanced recovery guidelines should be dynamic, allowing
modifications of certain aspects of the program as new data becomes available. Some authors
have advocated a rigid adherence to the ERAS protocol, citing study data that demonstrates
a proportional relationship between deviation from the protocol and increased morbidity [61].
However, as evidence for components of the ERAS protocol change, it may be that a more
flexible and individualised approach should be considered.
5. Perioperative fluid administration
Traditionally, patients undergoing major colorectal surgery have received liberal volumes of
intravenous fluids [49]. Excess intravenous fluid during and after surgery has been associated
with delayed gut function and increased complication rates [50, 51]. Fluid restriction has been
proposed as a possible method of improving recovery and reducing postoperative complica‐
tions. Brandstrup et al [58] found that randomising patients undergoing elective colorectal
surgery resection to a restricted fluid protocol reduced cardiopulmonary and wound morbid‐
ity. MacKay et al [59] found no difference in recovery of gastrointestinal function or time to
discharge with postoperative fluid restriction while using a conservative intra-operative
protocol. Goal directed fluid therapy via oesophageal Doppler (OD) monitoring offers an
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opportunity to individualise peri-operative fluid administration. OD provides a real time
representation of haemodynamic function, and has been shown to be comparable with other
methods for estimating cardiac output such as LIDCO. A number of studies have shown that
goal-directed fluids reduce morbidity, critical care admissions, and hospital stay [62]. It is not
clear however whether these benefits are still significant within an enhanced recovery protocol.
Other goal-directed techniques employ central venous oxygen saturation (ScvO2) as a surro‐
gate for mixed venous oxygen saturation. ScvO2 is related to tissue oxygenation and so can be
used to titrate oxygen and fluid therapy, particularly in the immediate postoperative period.
This approach requires central venous access which is not always available as some groups
have developed a less invasive approach to monitoring. While a number of different fluid
protocols have been proposed, the optimal approach is still unclear.
6. Evolving postoperative analgesia
Epidural analgesia was considered central to early ERAS protocols, since it reduces the
endocrine-mediated stress response [53, 54], and improves postoperative intestinal function
[55]. Epidural analgesia also provides superior pain control to systemic opiates, particularly
in the first 24-36 h after surgery [56]. Data on the effect of epidural analgesia come predomi‐
nantly from studies in open surgery while the benefits in laparoscopic surgery are less clear.
Levy et al [65, 66] performed a meta-analysis to address this question but concluded that there
was a paucity of quality data. The authors subsequently performed a study in which patients
were randomised to receive epidural, spinal or patient-controlled opiate analgesia following
elective laparoscopic colorectal resection. They demonstrated a significantly longer hospital
stay, time to return of bowel function and duration of nausea in the epidural group. Intra-
thecal morphine has been proposed as an alternative [67]. A meta-analysis provides encour‐
aging results in patients undergoing abdominal surgery; reduced post-operative pain in the
first 48 h and significantly reduced opiate consumption compared with systemic opiates [68].
Transversus abdominus plane blocks have also been gaining in popularity although compa‐
rative data is still lacking [69]. Epidurals can cause vasodilatation and hypotension [70],
resulting in excess fluid challenges, third space shift and fluid overload. As studies emerge
demonstrating benefits of alternative analgesic techniques, it does raise the question: Should
epidural analgesia be the standard technique for all colorectal resections? Perhaps a more
individualised approach dependent on the procedure, use of laparoscopy and placement of
incisions should be considered. In this way more patients may be able to avoid potential
complications while maintaining adequate analgesia and facilitating early mobilisation.
7. Laparoscopic and open surgery in enhanced recovery
The adoption of laparoscopic techniques within colorectal surgery came at a similar time to
the introduction of "fast-track" surgery. Early studies examining the effect of laparoscopic
surgery showed clear superiority in short term outcomes when compared with open surgery
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using traditional recovery technique [63, 64]. Patients undergoing laparoscopic surgery have
reduced in-patient stays, less morbidity and improved postoperative pain [65, 66]. What is less
clear is how much of the benefit is attributable to laparoscopy and how much is an effect of
differing perioperative care pathways. Since these early trials there have been a number of
small trials comparing laparoscopic and open colorectal surgery within an enhanced recovery
setting with conflicting results [55-61]. Most recently a four-armed randomised study of
patients undergoing either open or laparoscopic surgery, in an enhanced recovery or standard
recovery programme was performed. They demonstrated a significantly faster recovery time
following colonic surgery in those patients undergoing laparoscopic procedures within an
ERAS programme. What is clear is that there are still a number of areas within the enhanced
recovery protocol where the evidence-base continues to change. The relative contributions of
different facets of the protocol also remain to be determined. While this is the case we should
accept a flexible approach to facilitate the adoption of techniques supported by randomised
data. There may also be scope for a degree of individualisation to reflect the wide range of
patients and procedures to which enhanced recovery is now being applied. [70]
8. Laparoscopic colectomy
After the initial description in 1991, several reports of laparoscopic colectomy (LC) for
colorectal cancer were described. Significant concerns regarding this approach surfaced when
minimally invasive techniques applied to colorectal malignancy lead to increased surgical
complications and worse cancer outcomes compared to conventional open approaches. An
early report, using minimally invasive techniques for benign colorectal disease, showed a
significantly high rate of serious complications (18%), including inadvertent enterotomies,
intraoperative hemorrhage, anastomotic leaks, and pelvic abscesses. When LC was used to
treat colorectal cancer, several papers noted early wound or trocar site recurrences, including
one case series documenting a 21% rate. With a less than 1 percent wound implantation rate
for open surgery, serious concerns were raised as to the possibility that poor oncologic results
were due to a combination of poor technique and abnormal distribution of malignant cells
secondary to pneumoperitoneum. Further concerns that laparoscopic techniques may be
problematic to cancer patients arose when some studies demonstrated statistically significant
worse cancer-specific survival in patients who had conversion from laparoscopic to open
surgery. Moloo et al. described decreased survival at 2 years of 76% from 87% for all stages
(P = 0.02) of colorectal cancer collected from a prospective database of 377 consecutive
laparoscopic patients. In the same cohort, at 5 year followup, there was a trend toward
decreased overall survival in converted patients (61.9% versus 69.7%, P = 0.077). Chan et al.
showed an increased local recurrence rate at 3 year followup of 9.8% in the laparoscopically
converted group as compared to 2.8% in open patients (P = 0.03). The oncological concerns
raised in early reports provided a compelling argument to study the question of oncologic
equivalence between the open and laparoscopic approach to colorectal cancer in a controlled
fashion.
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In the early 1990s, several multicenter prospective randomized controlled trials comparing
laparoscopic and open surgery for colorectal cancer were initiated. Ultimately, seven large-
scale trials compared laparoscopic and open colectomy for colon carcinoma and examined
short-term and long-term outcomes. These trials included the Clinical Outcomes of Surgical
Therapies (COST) trial funded by the National Cancer Institute in the United States, the
Conventional versus Laparoscopic-Assisted Surgery in Colorectal Cancer (CLASICC) trial in
the United Kingdom, the Colon Cancer Laparoscopic or Open Resection (COLOR), a multi‐
center European trial, the Barcelona trial, and several others [20–26]. The main focus of these
trials was oncologic outcomes, but short-term outcomes, quality of life, and safety were also
evaluated. The CLASICC trial was the only large trial that also evaluated MIS in rectal cancer.
Though modest in early studies, the short-term patient-related advantages of laparoscopic
surgery have now been confirmed and are significant over the open approach. The Minimally
Invasive Colorectal Resection Outcomes (MICRO) review identified 22 randomized controlled
trials and 66 cohort series for benign and malignant colorectal disease [27]. Laparoscopic
colectomy results in significantly lower pain scores and analgesia requirements, estimated
blood loss, return of bowel function, and length of stay. Numerous other trials, including the
COST, COLOR, and CLASICC trials, examining short-term outcomes following laparoscopic
colectomy for colorectal cancer have confirmed these findings [20–26, 28]. Several studies have
also identified a decreased rate of postoperative morbidity including fewer wound infections
[21, 23, 27, 29]; this was recently reinforced by a large trial from the National Surgical Quality
Improvement Program (NSQIP) database of over 10, 000 patients identifying decreased
incidence of wound infection following laparoscopic colectomy (9.5% versus 16.1%, P < 0.001)
[30]. Quality of life has been assessed in several trials and results varied from no difference to
favoring improved quality of life in laparoscopic colectomy [31].
The initially cited oncologic concerns of laparoscopic colectomy for colorectal cancer were later
dispelled when surgeons trained in appropriate laparoscopic oncologic resection performed
operations in the trial setting. Major trials, including the COST, CLASICC, and COLOR trials,
examined tumor specimens and reported long-term data on recurrence and survival. The
surgical specimens were evaluated, and parameters such as lymph node yield, circumferential
resection margins, and longitudinal margins were quantified. No trial identified statistically
significant differences in lymph node yield [20–26] or resection margins [20, 22, 26]. This initial
evidence allayed some concerns regarding oncologic resections, but the long-term measures
for recurrence and survival were still unknown. Trial data matured, and more evidence
accumulated confirming similar recurrence patterns and rates between laparoscopic and open
colectomy. Local recurrence, distant recurrence, and wound or port site metastases were the
same between groups [4, 5, 7, 24, 32–34]. Disease-free and overall survival in long-term follow-
up (up to 7 years) is equivalent [4, 5, 7, 32–34]. The concern that conversion from laparoscopic
to open surgery in patients with colon cancer may lead to worse oncologic outcomes was not
seen when 5-year COST trial data showed no statistical difference in these two groups.
Despite evidence demonstrating improved short-term outcomes of laparoscopic colectomy
and oncologic equivalence, widespread implementation of this technique was slow. The lack
of formalized training, outside single-day laparoscopic training courses, and the significant
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learning curve for straight laparoscopic techniques likely represented significant barriers to
adoption. As hand-assisted laparoscopic surgery grew in popularity, a more widespread
adaptation with fewer conversions to open surgery occurred in part due to a shorter learning
curve with this technique. Three randomized controlled trials have been performed to compare
a hand-assisted technique to a laparoscopic technique including patients with both benign and
malignant disease, all demonstrating decreased rates of conversion to open surgery [35–37].
A recent meta-analysis compiling 13 studies demonstrated decreased operative times and
decreased open conversion rates with a hand-assisted approach [38]. There were no differences
in short-term clinical outcomes or oncologic resection results. A recent study by the Mayo
Clinic prospectively analyzed the use of hand-assisted surgery in a minimally invasive
colorectal practice and found that when applied to a center performing large volumes of
laparoscopic surgery, hand-assisted techniques were responsible for more complex proce‐
dures to be done laparoscopically [39]. This technique is a minimally invasive approach that
has been helpful for surgeons to transition from open to laparoscopic colectomy, especially if
they have had little previous laparoscopic experience. Moreover, this technique has allowed
a MIS approach in patients otherwise not previously considered candidates (obese, adhesions).
As surgeon experience increased and as more studies demonstrated that laparoscopic colec‐
tomy for benign and malignant disease is an acceptable alternative to open surgery, the overall
ratio of laparoscopic to open colectomies in the United States has increased. A recent analysis
from 2000 through 2004 demonstrated an increasing incidence of laparoscopic colectomy from
3% to 6.5% nationally with increased rates of laparoscopic approaches in urban centers and
teaching hospitals [40]. A separate study and database of patients from 2004 through 2006
identified over 32, 000 patients, of which 34% underwent laparoscopic colectomy [41]. This
trend toward increased laparoscopy has also been influenced by public knowledge and patient
demand for this approach, as well as improved and formalized laparoscopic training in
residency programs.
The short-term advantages of laparoscopic surgery over the open approach are confirmed. The
minimally invasive approach is characterized by lower pain score and analgesia requirement,
estimated blood loss; earlier return of bowel function and shorter length of stay (Minimally
Invasive Colorectal Resection Outcomes (MICRO), [20]. The postoperative recovery of
pulmonary function is quicker after laparoscopic colectomy. None of the randomized trials
have observed significant increase in the anastomotic leakage rate [2-5]. Several studies
demonstrated the decreased rate of postoperative morbidity and less wound infections [2-7].
Quality of life after laparoscopic surgery has been evaluated in several trials and the results
varied from similar to better QoL than after open surgery [21].
In 2008 Lacy et al. reported the long-term outcomes of Barcelona trial (median follow-up 95
months). The overall survival rate was higher in the laparoscopic (64%) group when compared
with the open group (51%) with no statistically significant difference (p<0.07). Laparoscopic
group demonstrated higher cancer-related survival and lower cancer recurrence in (p<0.07 for
both). The differences in survival and recurrences between the open and laparoscopic groups
were observed for III stage tumors, with significantly better results in terms of overall-survival,
cancer-related survival and chances of being free of recurrence. Results for stage I and II did
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not show any statistical difference. The conclusion is that in a dedicated laparoscopic center,
LAC may result in a long-term survival benefit compared with OC, particularly in advanced
cases”. This oncological advantage can be explained by a preserved cellular immunity,
attenuated stress and inflammatory response. [7]
These results seem encouraging and lead the way for laparoscopic surgery, although in a 2007
study by Fleshman (5-year follow-up, COST trial) the data did not demonstrate significant
difference in the 5-year overall survival, 5-year disease-free survival, and recurrence rates
between the two groups. The pattern of recurrence is also similar. [5] In 2007 Bonjer et al.
reported meta-analysis, based on 3-year follow-up data from Barcelona, COST, COLOR and
CLASSIC trials. No significant difference in 3-year survival, 3-year disease free survival or
tumor recurrence rates between study groups was observed. Analysis by stages did not show
any statistical difference in survival between both groups [16].
The hand-assisted laparoscopic surgery is a potential way to decrease operative time and
maintain the benefits of the minimally invasive approach. The type of laparoscopic surgery
allows introducing a hand through special device in the abdominal cavity, while preserving
pneumoperitoneum. This provides proprioception and tactile feedback and ability to perform
manual dissection and retraction. A study by Marcell [8] reported the results after multicenter
randomized trial. The hand assisted sigmoidectomy group had significantly shorter operative
time by 30-minutes when compared with straight laparoscopic group. Both groups had similar
short-term outcomes. There were no differences in time to bowel function, pain scores, narcotic
use, or time to bowel function. Conversion to open surgery was also significantly less for the
hand-assisted group. Incision length was significantly longer for the hand-assisted group, but
the difference was small. The authors concluded that hand-assisted surgery results in signifi‐
cantly shorter operative time, while maintaining similar outcomes as straight laparoscopic
surgery [17]. Hand-assisted surgery allows to perform more complex procedures and to
operate on patients with adhesion or obesity.
9. Laparoscopy for rectal cancer
The use of laparoscopic approach in the treatment of rectal cancer has led to increase of surgical
complications and worse cancer outcomes in comparison to the open surgery [6] strong
statement to make, may be phrase it differently. Several papers reported increased rate of port-
site recurrences, reaching up to 21% [3]. The same parameter for the open approach is 1%.
Those results might be explained by poor surgical technique and abnormal distribution of
cancer cell due to the pneumoperitoneum [7]. The cancer-specific survival was significantly
lower after conversion to open surgery [8, 9].
Based on the data of a prospective trial, including 377 laparoscopic patients [22] the survival
decreased from 87% to 76% at 2 years for all stages of colorectal cancer. After a 5-year follow-
up the overall survival decreased in converted patients. The local recurrence also proved to
be higher: 9.8% and 2.8% for the laparoscopic and open groups, respectively. Several large
trials were initiated in the 1990 (Clinical Outcomes of Surgical Therapies (COST) [21]in the
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USA, the Conventional versus Laparoscopic-Assisted Surgery in Colorectal Cancer (CLA‐
SICC) [6] in the United Kingdom, Colon Cancer Laparoscopic or Open Resection (COLOR) in
Europe and the Barcelona trial) [15]. Those trials evaluated laparoscopic and open colectomy
for colon carcinoma and examined short-term and long-term outcomes, as well as short-term
outcomes, quality of life and safety. Only the CLASSIC trials evaluated minimally invasive
surgery for rectal cancer.
The potential benefits of laparoscopic rectal surgery are known and were proven by meta-
analysis of studies of non-randomized trials – shorter time of bowel function restoration,
shorter length of stay [22]. A characteristic advantage of the laparoscopic surgery is that it
provides unobstructed view to the entire surgical team and magnified view of the operating
field, thus allowing more accurate dissection. The pneumoperitoneum helps to open the planes
of dissection of the mesorectum. The limitations of the laparoscopic rectal surgery are the
unsure data on oncological safety [2-5], the concerns about inadequate oncological distant
dissection, anastomotic leakage, technical challenges [23, 24].
Significant difficulty poses the obtaining of adequate exposure of the rectum. The narrow
pelvis in some patients may cause clashing of the instruments and poor dissection. An
experience assistant is required in such cases. The CLASSIC trial reported increased rate of
positive circumferential margin after laparoscopic rectal surgery (12%) in comparison to the
open group (6%). The distant margin of the tumor is difficult to be identified, as it cannot be
palpated. This may cause inadequate distal resection.
Figure 1. Laparoscopic resection of rectal cancer –anterior mobilization of the rectum
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The use of laparoscopic stapler requires multiple firings to complete distal rectal resection. In
the case of low rectal anastomoses, this increases the anastomotic leakage rate (17% below
12cm from the anal verge [11], 20% below 15cm [23]. The leakage rate after open total meso‐
rectal dissection varies from 4% to 11% [25, 26]. Future improvement of the stapler technology
is required.
Figure 2. Lymph node dissection in laparoscopic rectal cancer resection
The proven benefits of laparoscopy noted in colon cancer surgery including decreased
intraoperative blood loss, smaller length of incision, less postoperative pain, faster recovery
of intestinal function, and shorter length of hospital stay likely also apply to rectal cancer
surgery [37]. In RCTs the mean operative time for open surgical resection of rectal cancer
ranged from 106 to 284 min compared to 120 to 245 min for laparoscopic resection. As expected,
duration of operation was significantly longer in the laparoscopic group compared to the open
group in 6 of the 8 RCTs [7, 22, 31, 38-40]. Similar results were reported in RCTs of open vs
laparoscopic resection for colon cancer. Zhou et al [24] reported both shorter open and
laparoscopic operative times compared to other trials with no significant difference between
the two operative approaches (120 min vs 106 min for laparoscopic vs open resection respec‐
tively, P= 0.051). However, no details were provided on tumor stage, conversion rate, or
whether the analysis was performed on an intent-to-treat basis. Araujo et al [25] was the only
RCT to demonstrate significantly shorter operative times with laparoscopic compared to open
resection (228 min vs 284 min respectively, P = 0.04). However, they attributed these results to
fact that the surgical team performing laparoscopic APR was the same whereas open APR was
often performed by different surgical teams. In addition, extraction of the specimen from the
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perineum likely decreased operative time because there was not an abdominal incision to close.
Two meta-analyses included operative time as an outcome of interest. Aziz et al [17] included
22 studies comparing laparoscopic vs open rectal cancer resection in 2071 patients and found
that operative time was significantly increased with the laparoscopic group as compared to
the open group with a weighted mean difference (WMD) of 40.18 (95% CI, 26.46-56.13). Gao
et al [26] performed a meta-analysis of short-term outcomes after laparoscopic resection for
rectal cancer based on 11 studies and included 643 patients which reported no difference in
operating time between open and laparoscopic approaches with a WMD of 1.59 [1.2-1.98].
Intraoperative blood loss was significantly less for the laparoscopic group compared to the
open group in 4 of 6 RCTs and ranged from 20 mL to 321.7 mL and from 92 mL to 555.6 mL in
the laparoscopic and open groups respectively [31, 35, 38, 40]. Araujo et al [25] did not
specifically report on the amount of intraoperative blood loss but there was no statistically
significant difference in the need for blood transfusions between the two groups which was
attributed to the fact that in an APR the majority of blood loss occurs during the perineal
portion of the case which is the same regardless of surgical access.
A recent Cochrane review by Breukink et al [41] evaluating the safety and efficacy of elective
laparoscopic TME for the resection of rectal cancer found that in the majority of studies blood
loss was reduced with the laparoscopic approach although this did not translate to fewer blood
transfusions. Length of incision was measured in 3 of 8 RCTs and ranged from an average of
5 cm to 10 cm with the laparoscopic approach compared to an average of 19.1 cm to 22 cm with
the open approach [7, 38, 40]. Seven of the 8 trials reported a conversion rate which ranged
from 0%-34% [7, 38-40]. Conversion to the open approach was commonly defined as length of
incision greater than the size needed for tumor extraction or premature abdominal incision to
allow improved mobilization. In the majority of studies conversion to open surgery was
required because of local tumor invasion or difficult dissection in a narrow pelvis although
bulky tumor, dilated small bowel, dense adhesions, bleeding, rectal perforation, difficulty
mobilizing the splenic flexure, failure to identify or injury to the ureter, ischemia of the
descending colon, and anastomotic failure were also cited. Breukink et al [41] reported that 36
of 48 studies assessed conversion and showed a highly variable rate ranging from 0% to 33%.
However, they report that the lack of consensus in the definition made results difficult to
interpret. In addition, surgeon experience and patient selection criteria were often not
mentioned. Two trials reported particularly high rates of conversion. Ng et al [37] had a
conversion rate of 30.3% but they did not routinely perform preoperative staging with
computed tomography scans and therefore frequently converted after diagnostic laparoscopy.
Twelve of the 23 patients randomized to laparoscopic surgery were converted to open due to
local tumor invasion, bulky tumor, or dilated small bowel which may have been recognized
by preoperative imaging. In the CLASICC trial the conversion rate for laparoscopic resection
of rectal cancer was reported at 34% and attributed to excessive tumor fixation and uncertainty
of tumor clearance [6]. Surgeon learning curve may account for this high rate of conversion as
evidenced by the fact that the overall rate of conversion dropped by year of study from 38%
in year one to 16% in year six. However, consistent with several non-randomized reports, in
the CLASICC trial patients converted to open resection had a higher operative mortality
compared to patients in the laparoscopic or open groups (9% vs 1% vs 5% respectively) [6].
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Conversion was also associated with worse oncologic outcomes in nonrandomized compara‐
tive and descriptive studies [46].
Figure 3. Total mesorectal excision after laparoscopic rectal resection
10. Short-term oncologic outcomes
While the number of lymph nodes retrieved can vary based on age, gender, tumor site, use of
pre-operative radiation, and tumor grade, the extent and quality of surgical resection can also
have an impact on the number of nodes collected and is therefore often considered a surrogate
marker of the oncologic completeness of the resection [37]. The American Joint Committee on
Cancer recommends that at least 12 lymph nodes be examined in patients with rectal cancer
to confirm the absence of nodal involvement by the tumor [34]. In addition, a number of studies
have reported that the number of lymph nodes examined may be associated with patient
outcome [25, 26]. Six of the 8 RCTs reported the mean number of lymph nodes retrieved with
a range of 5.5 to 17 nodes in the laparoscopic group compared to 11.6 to 18 nodes in the open
group [22, 31, 34]. In 4 of the 6 trials the number of lymph nodes isolated was not significantly
different based on surgical approach. Araujo et al [25] reported a significantly lower yield of
lymph nodes with laparoscopic rectal resection compared to open resection (5.5 vs 11.9
respectively, P = 0.04). They suggested that laparoscopy offered better dissection and accuracy
due to better visualization and exposure of structures with less manipulation of the mesorec‐
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tum especially in a narrow pelvis. Four of the 8 RCTs reported the use of pre-operative
chemoradiation. In these trials, the mean number of lymph nodes retrieved ranged from 5.5
to 17 nodes in the laparoscopic group and from 11.6 to 18 nodes in the open group [31, 34, 38,
40]. Some authors [37] found that in the 17 trials that reported the number of lymph nodes
retrieved, the mean number of nodes was 10 for the laparoscopic group and 12 for the open
group (P = 0.001) with the majority of trials reporting a median of 11 or fewer nodes obtained.
In 9 of these 17 trials, both groups were treated with preoperative radiation therapy and
reported a mean of 10 lymph nodes harvested in the laparoscopic group and 11 in the open
group. One of the greatest concerns of laparoscopic TME is that obtaining a complete oncologic
resection will be more difficult. Involvement of the circumferential or distal margin is one of
the most important prognostic factors in rectal resection with TME and can lead to an increase
in local recurrence and a reduction in survival. Radial margins of less than 2 mm are associated
with a local recurrence rate of 16% compared to a significantly reduced local recurrence rate
of 6% with margins greater than 2 mm [27]. Six of the 8 RCTs reported the involvement of the
CRM and no difference was found by surgical approach [7, 31, 38-40, 45]. In the majority of
trials the rate of CRM involvement was less than 5%. Patients with positive radial margins
often had tumor invading the pelvic side wall or adjacent structure and were frequently
converted from a laparoscopic to an open procedure [39]. In the CLASICC study, the only
multicenter trial, a positive CRM was identified in 14 of 97 (14%) patients with open surgery
and in 30 of 193 (16%) patients with laparoscopic rectal resection [6]. Of patients undergoing
anterior resection, the CRM was positive in 16 of 129 (12%) individuals in the laparoscopic
group and in 4 of 64 (6%) individuals in the open group. While there is a non-significant higher
positivity of the CRM in the laparoscopic anterior resection group, this is once again likely due
to the fact that the learning curve was not completed before the start of this study. Two RCTs
reported on distal margin status and the incidence of distal margin positivity was not signif‐
icantly different between the two surgical approaches and in fact was 0% [3, 31]. All 3 meta-
analyses and the Cochrane review by Breukink et al [41] found no difference in positive margins
based on surgical access.
11. Postoperative course
Less postoperative pain, faster recovery of intestinal function, and shorter length of stay are
important benefits of laparoscopic colorectal surgery. Only 3 of 8 RCTs compared the exact
amount of post-operative pain medication and 2 of these studies reported a significant
reduction in analgesic use in the laparoscopic group [39, 40, 45]. Zhou et al [24] did not quantify
the exact usage of pain medication, but found no significant difference in the number of days
parental analgesics were necessary (4.1 vs 3.9 in the open and laparoscopic groups respective‐
ly). Resumption of bowel function was usually reported on post-operative days 3 to 5 and
ability to tolerate a solid food diet was reported on post-operative days 3 to 6 [7, 31, 35, 39, 40,
45]. In the majority of RCTs earlier bowel movements and diet advancement was reported with
the laparoscopic approach. The return of bowel function and reduction in wound pain was
thought to contribute to earlier discharge after laparoscopic surgery. While in a majority of
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trials, the length of stay was not significantly different between surgical approaches, there was
a trend toward decreased length of stay with laparoscopic rectal surgery. Breukink et al [41]
found that laparoscopic TME resulted in earlier return of normal diet, less pain, less narcotic
use and a shorter hospital stay.
12. Complications
Rectal cancer surgery is associated with a high rate of morbidity and mortality. Post-operative
mortality in RCTs ranged from 1%-4% and demonstrated no statistically significant difference
based on surgical approach. The rate of post-operative complications ranged from 6% to 69%
and with the exception of Zhou et al [24] did not differ significantly between laparoscopic and
open groups. Wound infection and urinary tract infection accounted for the majority of
perioperative complications in both groups. There was a higher incidence of wound infection
with the open approach however this did not reach statistical significance. Breukink et al [41]
found no difference in morbidity between the laparoscopic and open groups although there
was a trend toward lower morbidity with laparoscopic TME. Aziz et al [17] found no difference
in perioperative morbidity between the 2 groups while Gao et al [26] found that the overall
morbidity rate of the laparoscopic group was significantly lower than that of the open group.
Anastomotic leak is the most serious complication after sphincter sparing rectal cancer
resection especially with neoadjuvant chemoradiation. In addition, development of an
anastomotic leak is reported to be associated with decreased long-term survival and higher
rates of local recurrence after curative resection for colorectal cancer [39-43]. Operative
expertise and selective diversion in high risk patients has resulted in a anastomotic leak rate
of 1%-17% in most published series studying laparoscopic resection for rectal cancer [29, 30].
Consistent with reports from non-randomized comparative trials, RCTs demonstrated no
significant difference in the incidence of anastomotic leak between the laparoscopic and open
technique for the resection of rectal cancer. While the incidence of perioperative morbidity was
not different based on surgical access, fewer patients had long-term complications with
laparoscopic rectal cancer resection compared to the open approach. Adhesion related bowel
obstruction was the most common longterm morbidity. With a median follow-up of greater
than 9 years, Ng et al [37] found that adhesion-related obstruction requiring hospitalization
(18.9% vs 2.7%) and reoperation (6.8% vs 0%) was higher in the open group. They report a
cumulative probability of adhesion-related bowel obstruction at 10 years of 20.5% in the open
group and 3.9% in the laparoscopic group. [45] Data on long-term complications was not
separated by site of disease but the overall occurrence of incisional hernia (7.9% vs 10.9%, P =
0.32) and reoperation for adhesions (1.1% vs 2.5%, P = 0.30) was not statistically difference
between laparoscopic and open resection. Long-term studies need to be done to determine if
laparoscopy decreases the incidence of intra-abdominal adhesion formation by reduced
surgical trauma, less tissue handling, and smaller incisions.




The initial reports of the long-term outcomes after laparoscopic surgery for rectal cancer were
discouraging. Several randomized trials report of the rate of positive circumferential radial
margin in the laparoscopic group in comparison to the open group (12-5.9% and 6-4.2%,
respectively). The 3-year follow-up did not establish higher local recurrence rate – 7.0% and
7.8%, respectively. The local recurrence rate after laparoscopic and open abdomino-perineal
resection were 15.1% and 21.1%, respectively. The overall disease-free survival rate was also
similar after laparoscopic and open anterior resection 70.9% and 70.4% and APR – 49.8% and
46.9%. Other data demonstrated 5-year disease survival reaching 83.7% for laparoscopic and
80.4% for open surgery. According to a meta-analysis of 20 laparoscopic rectal cancer studies
between 1993 and 2004, including over 2000 patients, there is no significant difference in the
number of harvested lymph nodes [22]. Despite the encouraging results, the laparoscopic rectal
surgery could be fully evaluated only after long-term results are available. The ongoing studies
are the American College of Surgeons Oncology Group (ACOSOG) Z6051 trial from the U.S.;
the COLOR II trial from Europe, Canada, and Asia; and the Japanese Japan Clinical Oncology
Group (JCOG) 0040 trial.
A number of the clinical trials were performed to determine the safety and feasibility of the
laparoscopic approach for rectal adenocarcinoma and therefore the data we have for long-term
outcomes is limited [5]. Braga et al [48] found no difference in local recurrence (4.0% in the
laparoscopic group vs 5.2% in the open group, P= 0.97), overall five-year survival, or disease
free five-year survival based on surgical approach. With a median follow-up of 87.2 mo in the
laparoscopic group and 90.1 mo in the open group, Ng et al [45] demonstrated that after
curative resection, the probability of five-year survival was 75.2% vs 76.5% for laparoscopic
vs open APR respectively (P = 0.20). In addition, stage-by-stage comparison for the two groups
showed no statistical difference. There were no port site recurrences and overall recurrence
rates were not significantly different between the two groups (laparoscopic 20% vs open 25%,
P = 0.60). Despite the higher rate of circumferential margin positivity in patients undergoing
laparoscopic anterior resection in the CLASICC trial, there was no difference in local recur‐
rence, three- year overall or three-year disease free survival between the two approaches (open
OS 66.7% and laparoscopic OS 74.6%, P = 0.17; open DFS 70.4% and laparoscopic DFS 70.9%,
P = 0.72; open LR 7.0% and laparoscopic LR 7.98%, P = 0.70) [6]. In addition, there was no
significant difference in the rates of local recurrence, three-year overall survival, or three-year
disease-free survival in patients undergoing laparoscopic vs open APR [12]. However, the
sample size is small and therefore larger studies are needed for conclusive results. Ng et al [37]
published results of a randomized trial of laparoscopic vs open anterior resection for upper
rectal cancer with a median follow-up of 9 years. No difference in local recurrence, overall
survival, or disease-free survival was reported. Although these studies suggest comparative
oncologic outcomes between laparoscopic and open rectal cancer resection, they include small
sample sizes and are almost all are single institution studies, highlighting the need for large,
multi-center RCTs to provide confirmatory data. With a mean follow-up of 35 mo for both
groups, overall local recurrence was not statistically different between the 2 groups (laparo‐
scopic 7% vs open 8%, P = NS). Eleven studies provided sufficient data to compare overall
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survival. Overall survival was 72% for patients undergoing laparoscopic rectal cancer resection
and 65% for open resection at an average of 4.4 years (P = 0.5). Subset analysis by [36] dem‐
onstrated no significant difference between laparoscopic and open rectal cancer resection in
terms of local recurrence (laparoscopic 7.2% vs open 7.8%, P = 0.46), development of distant
metastases (laparoscopic 13.5% vs open 9.1%, P = 0.60), or cancer-related mortality (laparo‐
scopic 9% vs open 10%, P = 0.16). While, this data is encouraging, it is no conclusive.
14. Hybrid and hand-assisted laparoscopic rectal surgery
Some authors have introduced a new method of hybrid rectal surgery, aiming to combine the
benefits of open and laparoscopic approach. The colonic mobilization is performed laparos‐
copically, while the rectal dissection is performed through a Pfannenstiel incision. A retro‐
spective review established significantly longer hospital stay after hybrid procedures than
after open procedures [27].
Another method is the hand-assisted laparoscopic surgery. A special access device for the hand
is introduced in the abdomen. Compared with fully open techniques this method provides
shorter operative time. High ligation of vessels, splenic flexure takedown, and lateral mobili‐
zation may be accomplished in a shorter period time with a hand-assisted technique. In hand-
assisted laparoscopic surgery, rectal exposure and dissection can be either performed directly
through the incision using the open techniques or laparoscopically with manual assistance
[28]. This method combines the excellent laparoscopic view and the dissection techniques in
open surgery and provides tactile sensation.
By performing distal rectal division directly through the incision using the open surgical
staplers, hand-assisted laparoscopic rectal surgery may result in a lower anastomotic leakage
rate.
15. Summary
After rigorous evaluation the laparoscopic surgery for colon cancer has become the gold
standard. Laparoscopic colon resection for cancer, in experienced hands, can be performed safely
and reliably with many short-term benefits to the patients while resulting in at least equiva‐
lent long-term outcomes as open surgery, which is supported by level 1 data. In conclusion,
RCTs have demonstrated that laparoscopy does not adversely affect cancer related survival in
patients with adenocarcinoma of the colon. Concerns about the technical difficulty of TME may
have contributed to the exclusion of rectal cancer patients from most of these large multicen‐
ter RCTs resulting in little data on oncologic outcomes with laparoscopic rectal cancer resec‐
tion. Laparoscopic rectal dissection is technically more demanding than open and constraints
of a narrow pelvis may result in difficulty assessing and obtaining adequate surgical margins.
However, there are several proposed benefits of laparoscopic rectal resection. A clear and
magnified view of the pelvis provided by the improved optics of laparoscopy may aid sharp
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dissection for TME and assist in identification of vital pelvic structures including the ureters and
autonomic nerves. In addition, pneumoperitoneum may separate the parietal and visceral fascia
of the mesorectum facilitating dissection in this plane. Laparoscopic rectal cancer resection has
a steep learning curve but increased experience with both open and laparoscopic TME will lead
to shorter operating times and decreased morbidity. Current data suggests that laparoscopic
rectal cancer resection may benefit patients because of reduced blood loss, earlier return of bowel
function, and shorter hospital length of stay. Concerns that laparoscopic rectal cancer surgery
may compromise short-term oncologic outcomes including number of lymph nodes harvest‐
ed and CRM positivity do not appear to be supported by the available literature. However, there
is a paucity of data concerning long-term oncologic outcomes and complications with laparo‐
scopic rectal cancer surgery. There are two large, multicenter RCTs that are currently being
conducted: the COLOR II trial in Europe and the ACOSOG-Z6051 trial in the United States. Both
of these studies are comparing the laparoscopic and open approach for treatment of resectable
rectal cancer. Results from these trials will provide information on the long-term outcomes of
laparoscopic rectal cancer resection and are eagerly awaited. In view of the lack of level one data
on oncologic outcomes, laparoscopic TME for locally advanced, curable rectal cancer should
only be performed within the confines of a RCT.
Other potential, but less conclusively demonstrated benefits include better preservation of cell-
mediated immune function and reduced tumor cell proliferation. Although a similar level of
evidence does not yet exist for the laparoscopic rectal surgery for cancer, the evidence to date
suggests that it is likely that the ongoing large randomized trials will demonstrate clinical
benefits of laparoscopic rectal cancer surgery. New devices for minimizing of the abdominal
trauma are being developed. The steep learning curve, cost and difficult training are still
hindrance to the wide use of laparoscopic colon surgery.
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